(Q37870326)

24 August 2017

title

In vitro susceptibility of Mycoplasma hominis clinical isolates to tetracyclines, quinolones and macrolides (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Zmira Samra

1

1 reference

24 August 2017

Shoshana Rosenberg

series ordinal

2

1 reference

24 August 2017

Yigal Soffer

series ordinal

3

1 reference

24 August 2017

publication date

1 December 2002

1 reference

Diagnostic Microbiology and Infectious Disease

24 August 2017

published in

1 reference

24 August 2017

volume

44

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

359-361

1 reference

Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Mycoplasma hominis peritonitis after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Prosthetic valve endocarditis caused by Mycoplasma hominis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Etiology of acute pelvic inflammatory disease proven by laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Peritonitis due to Mycoplasma hominis and Ureaplasma urealyticum in a liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibil

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Hematoma infection with Mycoplasma hominis following transplant nephrectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Frequency of Mycoplasma hominis and Ureaplasma urealyticum infections in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Non-occurrence of Mycoplasma genitalium in clinical specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

The genital mycoplasmas (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900459-5

7 January 2021

10.1016/S0732-8893(02)00459-5

Identifiers

DOI

1 reference

24 August 2017

1 reference